Login / Signup

Heterogeneity in testing for infectious diseases.

Christian BerrigViggo AndreasenBjarke Frost Nielsen
Published in: Royal Society open science (2022)
Testing strategies have varied widely between nation states during the COVID-19 pandemic, in intensity as well as methodology. Some countries have mainly performed diagnostic testing while others have opted for mass-screening for the presence of SARS-CoV-2 as well. COVID passport solutions have been introduced, in which access to several aspects of public life requires either testing, proof of vaccination or a combination thereof. This creates a coupling between personal activity levels and testing behaviour which, as we show in a mathematical model, leverages heterogeneous behaviours in a population and turns this heterogeneity from a disadvantage to an advantage for epidemic control.
Keyphrases
  • sars cov
  • infectious diseases
  • coronavirus disease
  • single cell
  • emergency department
  • respiratory syndrome coronavirus
  • room temperature
  • drug induced
  • adverse drug
  • electronic health record